Patients with SLE may develop hyperprolactinemia due to either increased pituitary prolactin secretion under the influence of inflammatory cytokines or increased synthesis of prolactin by peripheral lymphocytes [26, 27]. This evidence concerns the gene PRL and hyperprolactinemia.